Monahan Joseph

Officer at ACRS

Sold, on record
$2.1M
Dollars the filings state
Form 4 sales
11
Latest Oct 23, 2023
Form 144 notices
3
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • ACRSAclaris Therapeutics, Inc.Officer

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale ACRSPlan not stated
    Feb 15, 2023 2023

    Sold 5,000 shares at $13.06 ($65k)

    Monahan Joseph, Chief Scientific Officer

    Sold 5.2% of holdings ($1.3M position)91,386 shares left0.4x usual sizeFiling

  2. 2 Form 4 sale ACRSUnusual
    Mar 3, 2023 +16 days

    Sold 30,837 shares at $12.51 ($386k)

    Monahan Joseph, Chief Scientific Officer

    Sold 17.3% of holdings ($2.2M position)147,724 shares left6.2x usual sizeFiling

  3. 3 Form 144 notice ACRSNotice
    Jun 20, 2023 +109 days

    Filed to sell 6,000 shares ($61k)

    Monahan Joseph, Officer

    10b5-1 plan1.2x usual sizeFiling

  4. 4 Form 4 sale ACRSRoutine
    Jun 20, 2023 same day

    Sold 6,000 shares at $10.28 ($62k)

    Monahan Joseph, Chief Scientific Officer

    10b5-1 planSold 4.1% of holdings ($1.5M position)141,724 shares left1.2x usual sizeFollows a Form 144Filing

  5. 5 Form 144 notice ACRSNotice
    Aug 21, 2023 +62 days

    Filed to sell 6,000 shares ($43k)

    Monahan Joseph, Officer

    10b5-1 plan1.1x usual sizeFiling

  6. 6 Form 4 sale ACRSRoutine
    Aug 21, 2023 same day

    Sold 6,000 shares at $7.32 ($44k)

    Monahan Joseph, Chief Scientific Officer

    10b5-1 planSold 4.2% of holdings ($1M position)135,724 shares left1.1x usual sizeFollows a Form 144Filing

  7. 7 Form 144 notice ACRSNotice
    Oct 23, 2023 +63 days

    Filed to sell 6,000 shares ($32k)

    Monahan Joseph, Officer

    10b5-1 plan1x usual sizeFiling

  8. 8 Form 4 sale ACRSRoutine
    Oct 23, 2023 same day

    Sold 6,000 shares at $5.08 ($30k)

    Monahan Joseph, Chief Scientific Officer

    10b5-1 planSold 4.4% of holdings ($689k position)129,724 shares left1x usual sizeFollows a Form 144Filing

Every transaction

Loading transactions…

Sales and notices (14)

Form 144 notices and Form 4 sales by Monahan Joseph
Source
Oct 23, 2023Oct 25, 2023ACRSChief Scientific OfficerForm 4 sale6,000$30k4.4%RoutineSEC
Oct 23, 2023Oct 23, 2023ACRSOfficerForm 144 notice6,000$32kNoticeSEC
Aug 21, 2023Aug 22, 2023ACRSChief Scientific OfficerForm 4 sale6,000$44k4.2%RoutineSEC
Aug 21, 2023Aug 21, 2023ACRSOfficerForm 144 notice6,000$43kNoticeSEC
Jun 20, 2023Jun 22, 2023ACRSChief Scientific OfficerForm 4 sale6,000$62k4.1%RoutineSEC
Jun 20, 2023Jun 20, 2023ACRSOfficerForm 144 notice6,000$61kNoticeSEC
Mar 3, 2023Mar 3, 2023ACRSChief Scientific OfficerForm 4 sale30,837$386k17.3%UnusualSEC
Feb 15, 2023Feb 17, 2023ACRSChief Scientific OfficerForm 4 sale5,000$65k5.2%Plan not statedSEC
Dec 15, 2022Dec 16, 2022ACRSChief Scientific OfficerForm 4 sale5,000$79k4.9%Plan not statedSEC
Oct 17, 2022Oct 19, 2022ACRSChief Scientific OfficerForm 4 sale5,000$80k4.7%Plan not statedSEC
Apr 18, 2022Apr 20, 2022ACRSChief Scientific OfficerForm 4 sale30,000$488k22.0%Plan not statedSEC
Mar 10, 2022Mar 14, 2022ACRSChief Scientific OfficerForm 4 sale27,165$427k16.6%Plan not statedSEC
Feb 9, 2022Feb 11, 2022ACRSChief Scientific OfficerForm 4 sale383$5k0.4%Plan not statedSEC
Jun 2, 2021Jun 2, 2021ACRSChief Scientific OfficerForm 4 sale21,790$471k20.3%Plan not statedSEC